Inventor · disambiguated record
Christopher P. Prior
Also filed as: PRIOR CHRISTOPHER · PRIOR CHRISTOPHER P · WEBER DAVID M
17 granted patents·20 pending applications·572 citations·filing 1987–2023
95Inventor score
Files withPRIOR CHRISTOPHER P59 METERS BIOPHARMA INC4BALLANCE DAVID J3BIOREXIS TECHNOLOGY INC3HUMAN GENOME SCIENCES INC3
Top patents by PatentIndex Score
37 records- 0198US7482013B2Albumin fusion proteinsHUMAN GENOME SCIENCES INC·Filed 2005·Granted Jan 27, 2009·82 cites·21 claims
- 0296US8158579B2Fusion protein of an exendin to modified transferrinBALLANCE DAVID JAMES·Filed 2010·Granted Apr 17, 2012·81 cites·5 claims
- 0396US7785599B2Albumin fusion proteinsHUMAN GENOME SCIENCES INC·Filed 2007·Granted Aug 31, 2010·30 cites·19 claims
- 0495US7507414B2Albumin fusion proteinsHUMAN GENOME SCIENCES INC·Filed 2005·Granted Mar 24, 2009·25 cites·19 claims
- 0595US7176278B2Modified transferrin fusion proteinsBIOREXIS TECHNOLOGY INC·Filed 2003·Granted Feb 13, 2007·129 cites·47 claims
- 0692US7867972B2Fusion protein of exendin-4 to a transferrin (Tf) polypeptidePHARMACIA & UPJOHN CO LLC·Filed 2007·Granted Jan 11, 2011·20 cites·11 claims
- 0787US5118796AEfficient large-scale purification of immunoglobulins and derivativesCENTOCOR INC·Filed 1987·Granted Jun 2, 1992·120 cites·19 claims
- 0886US9919032B2Method for administering a sustained release formulationPHASEBIO PHARMACEUTICALS INC·Filed 2016·Granted Mar 20, 2018·3 cites·20 claims
- 0981US10080785B2Albumin fusion proteinsBALLANCE DAVID J·Filed 2007·Granted Sep 25, 2018·2 cites·20 claims
- 1080US8946156B2Albumin Fusion ProteinsBALLANCE DAVID J·Filed 2012·Granted Feb 3, 2015·2 cites·19 claims
- 1170US8129504B2Oral delivery of modified transferrin fusion proteinsPRIOR CHRISTOPHER P·Filed 2003·Granted Mar 6, 2012·8 cites·2 claims
- 1270US2011280830A9Albumin Fusion ProteinsROSEN CRAIG A·Filed 2009·Application pending·0 cites
- 1365US2023340022A1Compounds and methods for treating tight junction permeability9 METERS BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1463US11608359B2Compounds and methods for treating tight junction permeabtility9 METERS BIOPHARMA INC·Filed 2019·Granted Mar 21, 2023·0 cites·18 claims
- 1563US5661023AProduction and purification of retroviral particles using tentacle anion exchangeIMMUNE RESPONSE CORP INC·Filed 1996·Granted Aug 26, 1997·19 cites·10 claims
- 1662US2012252732A1Albumin fusion proteinsBALLANCE DAVID J·Filed 2011·Application pending·0 cites
- 1758US5847086ATherapeutic fragments of von Willebrand factorCENTEON L L C·Filed 1995·Granted Dec 8, 1998·14 cites·28 claims
- 1858US2015290328A1Formulations of active agents for sustained releasePHASEBIO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1957US6080571AHighly efficient production and isolation of viral particles utilizing tentacle anion exchangeIMMUNE RESPONSE CORP INC·Filed 1997·Granted Jun 27, 2000·13 cites·7 claims
- 2056US2007066813A1Modified transferrin fusion proteinsPRIOR CHRISTOPHER P·Filed 2003·Application pending·0 cites
- 2153US5539086ATherapeutic fragments of von Willebrand factorRH & E CIR O & EE NE POULENC R·Filed 1994·Granted Jul 23, 1996·13 cites·18 claims
- 2253US2007050855A1Modified transferrin fusion proteinsPRIOR CHRISTOPHER P·Filed 2006·Application pending·0 cites
- 2351US2008220002A1Modified transferin-antibody fusion proteinsBIOREXIS TECHNOLOGY INC·Filed 2007·Application pending·0 cites
- 2450US2007060512A1Dipeptidyl-peptidase protected proteinSADEGHI HOMAYOUN·Filed 2004·Application pending·0 cites
- 2549US2014171370A1Formulations of active agents for sustained releasePHASEBIO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2648US2003226155A1Modified transferrin-antibody fusion proteinsBIOREXIS PHARMACEUTICAL CORP·Filed 2003·Application pending·0 cites
- 2747US2006105387A1Transferrin fusion proteins librariesPRIOR CHRISTOPHER P·Filed 2003·Application pending·0 cites
- 2846US2023218706A1Larazotide derivatives comprising d-amino acids9 METERS BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2946US2003004142A1Use of NSAIDs for prevention and treatment of cellular abnormalities of the lung or bronchial pathwayFiled 2002·Application pending·0 cites
- 3046US2013084277A1Formulations of active agents for sustained releaseARNOLD SUSAN·Filed 2012·Application pending·0 cites
- 3146US2007031440A1Modified transferin-antibody fusion proteinsPRIOR CHRISTOPHER P·Filed 2003·Application pending·0 cites
- 3245US2021069286A1Compositions and methods for treating or preventing hyperglycemia, insulin resistance, and associated organ damage9 METERS BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 3344US2011092677A1Modified transferin-antibody fusion proteinsBIOREXIS TECHNOLOGY INC·Filed 2010·Application pending·0 cites
- 3443US4898826AMethod to solubilize tissue plasminogen activatorINVITRON CORP·Filed 1987·Granted Feb 6, 1990·11 cites·8 claims
- 3541US2004023334A1Modified transferrin fusion proteinsBIOREXIS PHARMACEUTICAL CORP·Filed 2002·Application pending·0 cites
- 3641US2006205037A1Modified transferrin fusion proteinsSADEGHI HOMAYOUN·Filed 2006·Application pending·0 cites
- 3738US2003004143A1Use of NSAIDs for prevention and treatment of cellular abnormalities of the female reproductive tractFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher P. Prior files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →